Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04049032 · ClinicalTrials.gov registry record
Perinatal Opioid Use
A clinical trial of Pregnancy and Opioid Use, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 98
- Enrollment target
- 1
- Study location
NCT04049032: Completed study of Pregnancy and Opioid Use, sponsored by Medical University of South Carolina.
NCT04049032 is a study of Pregnancy and Opioid Use that has completed, run by Medical University of South Carolina. The registered enrollment target is 98 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04049032, a study of Pregnancy and Opioid Use, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare maternal and newborn outcomes among pregnant women with OUD receiving care via telemedicine versus in-person.
Primary Outcome
Uninterrupted addiction treatment during pregnancy through 6-8 weeks postpartum
Conditions Studied
Interventions
- BEHAVIORAL In-Person Perinatal OUD Treatment
- BEHAVIORAL Perinatal OUD Treatment via Telemedicine
Study Locations (1)
South Carolina
- The Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2018-12-31 |
What the finished NCT04049032 record still lists
NCT04049032 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which In-Person Perinatal OUD Treatment is the first listed.
NCT04049032 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT04049032 about?
NCT04049032 is a clinical study titled "Perinatal Opioid Use". To compare maternal and newborn outcomes among pregnant women with OUD receiving care via telemedicine versus in-person.
What is the current status of trial NCT04049032?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2017-09-01. Estimated completion is 2018-12-31.
What conditions does trial NCT04049032 study?
This clinical trial studies the following conditions: Pregnancy, Opioid Use.
What interventions are being tested in trial NCT04049032?
The interventions under investigation include: In-Person Perinatal OUD Treatment (BEHAVIORAL), Perinatal OUD Treatment via Telemedicine (BEHAVIORAL).
Who is sponsoring clinical trial NCT04049032?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04049032 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04049032's enrollment target sits among peer trials
98 121st of 191 higher than 71 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI